Factor 5 mutation profile in German patients with homozygous and heterozygous factor V deficiency

Haemophilia

Volumn 15, Issue 5, 2009, Pages 1143-1153

  Delev, Daniel ^a   Pavlova, A ^a   Heinz, S ^b   Seifried, E ^b   Oldenburg, J ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Factor V deficiency; Mutation distribution; Mutation profile

Indexed keywords

BLOOD CLOTTING FACTOR 5; GENOMIC DNA;

AMINO ACID SUBSTITUTION; ARTICLE; BLEEDING; BLOOD CLOTTING FACTOR 5 DEFICIENCY; CAUSAL ATTRIBUTION; CHILD; CLINICAL ARTICLE; DNA SEQUENCE; EXON; FEMALE; GENE ACTIVITY; GENE DELETION; GENETIC VARIABILITY; GERMANY; HETEROZYGOTE DETECTION; HOMOZYGOSITY; HUMAN; MALE; MISSENSE MUTATION; MUTATIONAL ANALYSIS; NONSENSE MUTATION; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; SCHOOL CHILD; SITE DIRECTED MUTAGENESIS;

CODON, NONSENSE; COHORT STUDIES; DNA MUTATIONAL ANALYSIS; FACTOR V; FACTOR V DEFICIENCY; FEMALE; GENOTYPE; GERMANY; HUMANS; MALE; MUTATION, MISSENSE; SEQUENCE ANALYSIS, DNA;

EID: 69949091321     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2009.02048.x     Document Type: Article

References (35)

1. Jenny RJ, Mann KG. Factor V: A prototype pro-cofactor for vitamin K-dependent enzyme complexes in blood clotting. Baillieres Clin Haematol 1989; 2: 919-44.
2. Tuddenham EG, Cooper DN. FactorV. The Molecular Genetics of Haemostasis and Its Inherited Disorders. Oxford: Oxford University Press, 1994.
3. Mann KG, Kalafatis M. Factor V: A combination of Dr Jekyll and Mr Hyde. Blood 2003; 101: 20-30.
4. Kalafatis M, Egan JO, van't Veer C, Cawthern KM, Mann KG. The regulation of clotting factors. Crit Rev Eukaryot Gene Expr 1997; 7: 241-80.
5. Kane WH, Davie EW. Blood coagulation factors V and VIII: Structural and functional similarities and their relationship to hemorrhagic and thrombotic disorders. Blood 1988; 71: 539-55.
6. Macedo-Ribeiro S, Bode W, Huber R et al. Crystal structures of the membrane-binding C2 domain of human coagulation factor V. Nature 1999; 402: 434-9.
7. Zaitsev VN, Zaitseva I, Papiz M, Lindley PF. An X-ray crystallographic study of the binding sites of the azide inhibitor and organic substrates to ceruloplasmin, a multi-copper oxidase in the plasma. J Biol Inorg Chem 1999; 4: 579-87.
8. Adams TE, Hockin MF, Mann KG, Everse SJ. The crystal structure of activated protein C-inactivated bovine factor Va: Implications for cofactor function. Proc Natl Acad Sci USA 2004; 101: 8918-23.
9. Pratt KP, Shen BW, Takeshima K, Davie EW, Fujikawa K, Stoddard BL. Structure of the C2 domain of human factor VIII at 1.5 A resolution. Nature 1999; 402: 439-42.
10. Orban T, Kalafatis M, Gogonea V. Completed three-dimensional model of human coagulation factor va. Molecular dynamics simulations and structural analyses. Biochemistry 2005; 44: 13082-90.
11. Kalafatis M. Coagulation factor V: A plethora of anticoagulant molecules. Curr Opin Hematol 2005; 12: 141-8.
12. Foster WB, Nesheim ME, Mann KG. The factor Xa-catalyzed activation of factor V. J Biol Chem 1983; 258: 13970-7.
13. Suzuki K, Dahlback B, Stenflo J. Thrombin-catalyzed activation of human coagulation factor V. J Biol Chem 1982; 257: 6556-64.
14. Kalafatis M, Rand MD, Mann KG. The mechanism of inactivation of human factor V and human factor Va by activated protein C. J Biol Chem 1994; 269: 31869-80.
15. Koeleman BP, Reitsma PH, Bakker E, Bertina RM. Location on the human genetic linkage map of 26 genes involved in blood coagulation. Thromb Haemost 1997; 77: 873-8.
16. Jenny RJ, Pittman DD, Toole JJ et al. Complete cDNA and derived amino acid sequence of human factor V. Proc Natl Acad Sci USA 1987; 84: 4846-50.
17. Lak M, Sharifian R, Peyvandi F, Mannucci PM. Symptoms of inherited factor V deficiency in 35 Iranian patients. Br J Haematol 1998; 103: 1067-9.
18. Peyvandi F, Mannucci PM. Rare coagulation disorders. Thromb Haemost 1999; 82: 1207-14.
19. Schrijver I, Hong DW, Mandle L et al. High frequency of premature termination mutations in the factor V gene: Three factor V deficiency case reports and a mutation review. Thromb Haemost 2005; 93: 610-1.
20. Asselta R, Montefusco MC, Duga S et al. Severe factor V deficiency: Exon skipping in the factor V gene causing a partial deletion of the C1 domain. J Thromb Haemost 2003; 1: 1237-44.
21. Duga S, Montefusco MC, Asselta R et al. Arg2074Cys missense mutation in the C2 domain of factor V causing moderately severe factor V deficiency: molecular characterization by expression of the recombinant protein. Blood 2003; 101: 173-7.
22. Montefusco MC, Duga S, Asselta R et al. A novel two base pair deletion in the factor V gene associated with severe factor V deficiency. Br J Haematol 2000; 111: 1240-6.
23. Montefusco MC, Duga S, Asselta R et al. Clinical and molecular characterization of 6 patients affected by severe deficiency of coagulation factor V: Broadening of the mutational spectrum of factor V gene and in vitro analysis of the newly identified missense mutations. Blood 2003; 102: 3210-6.
24. Castoldi E, Lunghi B, Mingozzi F et al. A missense mutation (Y1702C) in the coagulation factor V gene is a frequent cause of factor V deficiency in the Italian population. Haematologica 2001; 86: 629-33.
25. Ajzner EE, Balogh I, Szabo T, Marosi A, Haramura G, Muszbek L. Severe coagulation factor V deficiency caused by 2 novel frameshift mutations: 2952delT in exon 13 and 5493insG in exon 16 of factor 5 gene. Blood 2002; 99: 702-5.
26. Bossone A, D'Angelo F, Santacroce R, De LD, Margaglione M. Factor V Arg2074Cys: A novel missense mutation in the C2 domain of factor V. Thromb Haemost 2002; 87: 923-4.
27. Vos HL. An online database of mutations and polymorphisms in and around the coagulation factor V gene. J Thromb Haemost 2007; 5: 185-8.
28. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
29. Pettersen EF, Goddard TD, Huang CC et al. UCSF Chimera - a visualization system for exploratory research and analysis. J Comput Chem 2004; 25: 1605-12.
30. Asselta R, Tenchini ML, Duga S. Inherited defects of coagulation factor V: The hemorrhagic side. J Thromb Haemost 2006; 4: 26-34.
31. Ng PC, Henikoff S. SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res 2003; 31: 3812-4.
32. Ramensky V, Bork P, Sunyaev S. Human non-synonymous SNPs: Server and survey. Nucleic Acids Res 2002; 30: 3894-900.
33. Delev D, Pavlova A, Heinz S et al. Modelling and expression studies of two novel mutations causing factor V deficiency. Thromb Haemost 2008; 100: 766-72.
34. Guasch JF, Lensen RP, Bertina RM. Molecular characterization of a type I quantitative factor V deficiency in a thrombosis patient that is "pseudo homozygous" for activated protein C resistance. Thromb Haemost 1997; 77: 252-7.
35. Huang JN, Koerper MA. Factor V deficiency: A concise review. Haemophilia 2008; 14: 1164-9.